Procept Ebitda from 2010 to 2025

PRCT Stock  USD 76.02  2.82  3.58%   
Procept Biorobotics EBITDA yearly trend continues to be comparatively stable with very little volatility. EBITDA will likely drop to about -92.7 M in 2025. From the period from 2010 to 2025, Procept Biorobotics EBITDA quarterly data regression had r-value of (0.79) and coefficient of variation of (39.99). View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-88.3 M
Current Value
-92.7 M
Quarterly Volatility
21.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 2.2 M, Interest Income of 6.7 M or Depreciation And Amortization of 3.6 M, as well as many indicators such as Price To Sales Ratio of 15.89, Dividend Yield of 0.0 or PTB Ratio of 6.67. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.
  
Check out the analysis of Procept Biorobotics Correlation against competitors.

Latest Procept Biorobotics' Ebitda Growth Pattern

Below is the plot of the Ebitda of Procept Biorobotics Corp over the last few years. It is Procept Biorobotics' EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procept Biorobotics' overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Procept Ebitda Regression Statistics

Arithmetic Mean(53,898,830)
Geometric Mean50,695,296
Coefficient Of Variation(39.99)
Mean Deviation17,642,120
Median(40,953,000)
Standard Deviation21,552,518
Sample Variance464.5T
Range57.1M
R-Value(0.79)
Mean Square Error184.6T
R-Squared0.63
Significance0.0002
Slope(3,590,683)
Total Sum of Squares6967.7T

Procept Ebitda History

2025-92.7 M
2024-88.3 M
2023-98.1 M
2022-77.7 M
2021-51.1 M
2020-45.1 M

About Procept Biorobotics Financial Statements

Procept Biorobotics shareholders use historical fundamental indicators, such as Ebitda, to determine how well the company is positioned to perform in the future. Although Procept Biorobotics investors may analyze each financial statement separately, they are all interrelated. The changes in Procept Biorobotics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Procept Biorobotics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EBITDA-88.3 M-92.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Procept Stock Analysis

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.